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of a similar decline in the mean number of embryos resulting from superovulation or in the pregnancy rate following embryo transfer (24) ; indeed, in studies that have compared AI and embryo transfer in lactating cows, embryo transfer has consistently resulted in improved pregnancy rates when good quality embryos were transferred (1, 10, 11, 35) .
It is clear that oocytes and early embryos in superovulated animals develop under abnormal endocrine conditions that differ substantially from those in unstimulated (i.e., singleovulating) animals and that they may exhibit a reduced developmental potential (21, 28) . We have recently shown that development of the early bovine embryo in an environment of supraphysiological progesterone (P4) associated with superovulation procedures leads to significant alterations in the blastocyst transcriptome (17) . However, whether these changes represent functional changes or simply reflect the plasticity of the embryo transcriptome is unknown. This is especially relevant given the fact that the entire commercial embryo transfer industry in cattle, in which more than one million embryos are transferred worldwide annually (42) , has traditionally been based on the use of superovulation.
The abnormal endocrine environment generated as a consequence of the superovulation process not only affects the transcriptome of the embryo but clearly has consequences for the female reproductive tract and its subsequent capability to establish uterine receptivity. Elevated concentrations of P4, within the normal physiological range, in the immediate postovulatory period have been shown to significantly alter the pattern of endometrial gene expression by advancing the temporal changes that occur normally as well as advancing elongation of the conceptus (6, 14, 18, 38) . This effect has been shown to be a consequence of priming of the endometrium, presumably resulting in alterations of the histotroph composition, rather than a direct effect on the conceptus (9) . In support of this hypothesis, administration of P4 early in the estrous cycle can advance uterine receptivity for the transfer of older asynchronous embryos (19) .
The aim of this study was to analyze the changes induced in the endometrial transcriptome associated with superovulation in cattle. These data have relevance not only for cattle embryo production but also for assisted reproduction in humans where embryos derived from women undergoing controlled ovarian hyperstimulation are routinely replaced in the uterus of the same women during the same cycle, in contrast to the situation in cattle, where transfer to unstimulated surrogate recipients is the norm. The specific objectives of the study were 1) to assess the effect of elevated P4 concentrations on the endometrial tran-scriptome on day 7, the day when embryo recovery routinely takes place after superovulation in cattle, and 2) to place these observations in the context of our previous data on changes in the endometrial transcriptome associated with elevated P4 concentrations within the physiological range (14) and those changes induced in the embryo due to superovulation (17) .
MATERIALS AND METHODS
Animal model and tissue collection. All experimental procedures involving animals were licensed by the Department of Health and Children, Ireland, in accordance with the Cruelty to Animals Act (Ireland 1876) and the European Community Directive 86/609/EC and were sanctioned by the Animal Research Ethics Committee of University College Dublin. Unless otherwise stated, all chemicals were sourced from Sigma (Dublin, Ireland). All heifers (predominantly Charolais and Limousin cross-bred beef heifers: ϳ18 mo old) were housed indoors on slats and had ad libitum access to a diet of grass and maize silage supplemented with a standard beef ration. Estrous cycles were synchronized using an eight-day controlled internal drug releasing (CIDR) device (1.94 g progesterone InterAg, Hamilton, New Zealand). One day prior to CIDR removal, each heifer received a 0.5 mg intramuscular injection of a prostaglandin F2␣ analog (Estrumate; Shering-Plough Animal Health, Hertfordshire, UK). Only those heifers observed in standing heat were used and were randomly assigned to either control (unstimulated, n ϭ 8) or superovulated (n ϭ 9) groups. Heifers in the superovulated group received eight injections of FSH (455 IU of FSH in total: Folltropin; Bioniche, Bellesville, Canada) beginning on day 10 of a synchronized cycle as described previously (33) . All heifers were inseminated with semen from the same Limousin bull. Blood samples were taken daily by jugular vein puncture up to the day of slaughter (day 7) to measure changes in circulating P4 concentrations.
Following slaughter, the reproductive tracts of the heifers were recovered, the ovaries removed and corpora lutea (CL) dissected from the ovaries. Both uterine horns were flushed with 20 ml of PBS containing 10% FCS. Only those heifers, from which at least one embryo at the appropriate developmental stage (late morula to blastocyst) was recovered were processed further. Each uterine horn was opened longitudinally, and strips of endometrium containing predominantly intercaruncular endometrial tissue were carefully removed and processed as previously described (14) . Endometrial samples were then immersed in 1:5 wt/vol of RNAlater and stored at 4°C for 24 h. Excess RNAlater was removed, and the tissue was stored at Ϫ80°C prior to RNA extraction.
Microarray analysis. Total RNA was extracted (n ϭ 5 animals per treatment) with TRIzol reagent (Invitrogen, Carlsbad, CA) as per manufacturer's instructions. RNA cleanup and on-column DNase digestion was performed using the Qiagen mini kit (Qiagen, Crawley, West Sussex, UK). The quantity of RNA was determined by the Nanodrop 1000 (Thermo Fischer Scientific), and the quality of the RNA was determined using the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA). All RNA used for further transcriptomic analysis had an RNA integrity number of Ͼ8.0. Transcriptomic analysis was carried out using the Affymetrix GeneChip Bovine Genome Array, and all microarray protocols were carried out by Almac Diagnostics (Craigavon, Armagh, Northern Ireland) as previously described (14) . Briefly, total RNA (2 g) was converted to cDNA via first and second strand synthesis using the GeneChip Expression 3=-Amplification One-Cycle cDNA Synthesis kit. Biotinlabeled cRNA was synthesized from double-stranded cDNA using the GeneChip Expression 3=-Amplification in vitro transcription Labeling Kit. cRNA quality was assessed and fragmented, and sample clean-up performed at 94°C for 35 min. Quality was again accessed on the Agilent Bioanalyzer, and 15 g of fragmented cRNA and hybridization cocktail were added to the GeneChip Bovine Genome Array and hybridized for 16 h at 45°C. Each array was then washed and stained on the GeneChip fluidics station 450 using the appropriate fluidics script, and once completed the array was inserted into the Affymetrix autoloader carousel and scanned using the GeneChip Scanner 3000.
For analysis of the microarray data, raw signal intensities were read into R and preprocessed using functions of both affy and GCRMA packages of the BioConductor project (20) . Between-group analysis (12) was performed to determine the greatest source of variation in the tissue samples. Differences in gene expression between control and 
All primers were used at a concentration of 300 nm. superovulated endometria were identified using the Limma package (39) employing linear modeling and an empirical Bayes framework to shrink the variance of measurements on each probe set. A modified t-test was then carried out and all P values were adjusted for multiple testing using the Benjamini and Hochberg false discovery rate method.
Quantitative real-time PCR analysis. Quantitative real-time PCR (qRT-PCR) analysis was carried out on a panel of selected genes on the basis of the top up-and downregulated genes to validate the findings of the microarray. We used 1 g of RNA for microarray analysis, which was converted to complementary DNA (cDNA) using Superscript III (Applied Biosystems, Foster City, CA) and random hexamers as per manufacturer's instructions. All primers were designed using Primer-BLAST software (http://www.ncbi.nlm.nih.gov/tools/ primer-blast/) to span exon-exon boundaries where possible. Each qRT-PCR reaction was carried out on the 7500 Fast Real-Time PCR System (Applied Biosystems) with 50 ng of cDNA, optimized primer concentrations (Table 1) , 7.5 l FAST Sybrgreen mastermix (Applied Biosystems) in a final reaction volume of 15 l. Cycling conditions were as follows: 2 min at 50°C, 10 min at 95°C, and 40 cycles of 95°C for 15 s and 60°C for 1 min and were carried out with the inclusion of a dissociation curve to ensure specificity of amplification. A standard curve was included for each gene of interest as well as for the normalizer gene to obtain primer efficiencies. All raw cycle threshold values were then imported into qbase plus software (Biogazelle, Zwijnaarde, Belgium) where data were calibrated and normalized, and relative expression values for each gene were determined in arbitrary units (CNRQ). Following log transformation of the data, analysis of differences in transcript abundance between the control and superovulated groups was carried out by Student's t-test with significance set at P Ͻ 0.05.
Ingenuity pathway and interaction network analysis.
Following validation of microarray data by qRT-PCR, the list of differentially expressed genes (DEGs) generated by the microarray was further interrogated using Ingenuity Pathway Analysis (IPA: http://www. ingenuity.com) to identify the pathways, molecular functions and gene interaction networks associated with this list. A P value for a given function was calculated by considering the number of functional analysis molecules that participate in that function (e.g., ligand, receptor etc.) and the total number of molecules that are known to be associated with that function/pathway in the Ingenuity Knowledge Base. Functions and pathways with a P value Ͻ0.05 were considered significant and the ratio indicated the number of genes for a particular pathway/ontology in a gene list compared with the total number of genes in that specific pathway/ontology. Interaction networks were generated for the list of DEGs by identifying genes that serve as molecules of interest or that interact with other molecules in the Ingenuity Knowledge Base. These genes were identified as "network-eligible" molecules and were used as "seed" molecules to generate a network. These network eligible molecules were combined into networks that maximize their specific connectivity, which was identified as their interconnectedness with each other relative to all molecules they were connected to in the Ingenuity Knowledge Base. Additional molecules from the Ingenuity Knowledge Base were used to specifically connect two or more smaller networks and merge them into a larger one with a limit of 35 molecules for each interaction network generated. The networks generated were scored based on the number of network-eligible molecules they contain. The network score was based on the hypergeometric distribution and calculated with the right-tailed Fisher's exact test. The higher the score for a given interaction network, the lower the probability of finding the observed number of network eligible molecules in a given network by chance.
Progesterone analysis. Analysis of P4 concentrations in serum was carried out using the solid phase RIA Coat-A-Count progesterone kit (Siemens Medical Solutions Diagnostics, Los Angeles, CA) as previously described (13) . We place 100 l of serum in antibody-coated tubes in duplicate, and 750 l of iodinated P4 tracer was added to each tube. Following incubation at room temperature for 3 h, tubes were decanted and counted for 90 s using a Wallac 1470 gamma counter (Perkin Elmer). The intra-assay CVs were 15.8, 9.8, and 8.3% for the low, medium, and high quality control serum samples, respectively. The sensitivity of the assay was 0.03 ng P4/ml as previously reported (10) .
RESULTS

Effect of superovulation on P4 concentrations and endometrial gene expression.
Mean serum P4 concentrations were significantly higher from day 4 to day 7 in superovulated compared with unstimulated control heifers (Fig. 1) . In superovulated heifers for which gene expression analysis was performed, the average number of CLs observed on each pair of ovaries was 28.8 (Ϯ7.0 SE). Between-group analysis of the The direction of fold change is relative to expression in superovulated endometria. IPA, Ingenuity Pathway Analysis; DEG, differentially expressed gene. microarray data revealed a clear separation in the overall transcriptomic profile of endometria from unstimulated control heifers compared with superovulated heifers (Fig. 2) , which was reflected in the number of DEGs identified between the two groups (n ϭ 1,234). The proportion of DEGs that increased in response to superovulation was larger than those that decreased (795 and 439 DEGs, respectively; Supplementary Table S1 ). 1 Of the 12 genes chosen for qRT-PCR validation, the expression patterns of 10 genes were similar between both microarray and qRT-PCR platforms. Superovulation significantly decreased the expression of six of the 10 genes (Fig. 3:  CDCA5, CDCA8, KIAA0101, TOP2A, TROAP, and UBE2C) , while the expression of the remaining four genes (AK7, Bt23889, CFHR3, and GRM7) increased in superovulated endometria compared with controls (P Ͻ 0.05).
Pathways and interacting genes altered in the endometrium as a consequence of superovulation. IPA analysis indicated that the molecular and cellular functions that were altered to the greatest extent due to superovulation were involved in cell cycle (n ϭ 96 DEGs), lipid metabolism (n ϭ 54), small molecule biochemistry (n ϭ 73), vitamin and mineral metabolism (n ϭ 22), and cellular movement (n ϭ 107). The top five canonical pathways with a larger than expected number of genes altered are shown in Table 2 and include the pathway cell cycle: G2/M DNA damage checkpoint regulation (Fig. 4) , in which the expression of TP53, CHK1, TOP2, RPRM, CDC2, and CTNNB1 was decreased, while MDM2 and CDK7 increased in superovulated endometria.
The interaction networks identified for all 1,234 DEGs were involved in the biological processes of 1) infectious, inflammatory, and ophthalmic disease, 2) lipid metabolism, small molecule biochemistry, and vitamin and mineral metabolism (Fig. 5), 3) cell cycle, hair and skin development and function, and cancer 4) DNA replication, recombination and repair, cell death, and cell cycle, and 5) cancer, gastrointestinal disease and endocrine system development and function.
Comparison with other models of P4 manipulation. Our previously published data have shown that elevating P4 concentrations within physiological ranges by insertion of a P4 releasing intravaginal device on day 3 of pregnancy advances the temporal changes that normally occur in endometrial gene expression (14) , resulting in advanced conceptus elongation (6) . Ten times more genes were altered by superovulation (n ϭ 1,234) compared with the number altered due to elevated P4 1 The online version of this article contains supplemental material. Fig. 5 . Ingenuity Pathway Analysis derived interaction network involving genes involved in lipid metabolism, small molecule biochemistry, and vitamin and mineral metabolism. The network displays nodes (genes/gene products) and edges (the biological relationship between nodes). The color of the nodes indicates increased (red) or decreased (green) expression for a particular gene in endometria from superovulated compared with unstimulated controls on day 7 of pregnancy. The intensity of the color reflects the degree of fold-change, i.e., the more intense the color the larger the fold change difference in superovulated compared with unstimulated controls. A solid line indicates a direct interaction between nodes (genes/gene products) and a dashed line indicates an indirect relationship between nodes. The shape of the node is indicative of its function (See supplementary legend 1: http://www.ingenuity. com).
within physiological ranges (n ϭ 124) on day 7 following estrus. Surprisingly, however, only 22 DEGs were common to both models of P4 manipulation (Fig. 6A) .
Given that elevated P4 within physiological ranges advances endometrial gene expression, we hypothesized that continued exposure of superovulated endometria to abnormally high P4 concentrations may advance the endometrial transcriptome such that it would be more similar to that observed later during the luteal phase (day 13). Specifically, comparison of the DEGs due to superovulation on day 7 to those that are upregulated on day 13 (compared to day 7) in normal pregnant heifers (14) revealed 355 DEGs in common between these two groups (Fig. 6A) .
Comparison of effect of superovulation on the blastocyst and endometrial transcriptome. We recently published data on the differences in the transcriptome of bovine blastocysts derived from single-ovulating (unstimulated) heifers compared with superovulated animals using the Affymetrix platform (17) . Comparison of these data to those presented in this paper using the same data analysis criteria revealed substantially fewer genes affected by superovulation in the embryo compared with the endometrium (1,234 vs. 443 DEGs). Only 25 DEGs were common to both tissue types (Fig. 6B) , and only 10 of these 25 genes (ANO2, EPCAM, ERAS, EXOSC9, FAM60A, PWWP2A , SLC39A2, and three probe sets with unknown function) had similar expression patterns in both the endometrium and embryo i.e., upregulated due to superovulation. In contrast, the expression of ABCB8, ANLN, ATP1B3, CD151, CDC2, COL12A1, FTSJ2, KIT, LGALS3, LOC532409, PSMG2, TOP2A, YWHAG, as well as two genes with unknown function was decreased in the endometrium due to superovulation but was increased in embryos derived from superovulated cattle on day 7 (Tables 3 and 4) .
DISCUSSION
The results of this study indicate a relationship between supraphysiological concentrations of P4, a consequence of the process of superovulation and the induction of multiple CL, and the substantial changes in the endometrial transcriptome on day 7, the day embryos are normally recovered from donor animals for transfer to synchronized recipients. In all analyses performed i.e., gene ontology, overrepresented pathways and interaction networks, superovulation affected the expression of genes involved in cell cycle progression. One of the major effects of P4 in the endometrium of a number of species is its antiproliferative actions on estrogen-primed endometrial cells, in particular in species with invasive types of placentation such as mice (16) . P4 suppresses cellular proliferation in the epithelial cells of the endometrium by promoting binding of CDC2 to CCNB1, increasing G1/S phase arrest and increasing the expression of cell cycle-dependent kinase inhibitors e.g., p53 (44) . Addition of exogenous P4 can inhibit endometrial cell proliferation by decreasing CCNB1 protein abundance and thereby increasing cell cycle arrest at the G2/M phase and apoptosis (43) . In the current study, endometrial expression of both CDC2 and CCNB1 was decreased following superovulation, indicating that cellular proliferation may be altered. Con- Table 3 . Genes altered within 3 biological processes in both blastocyst (14) Positive values indicate increased expression in superovulated tissue, while negative values indicate decreased expression in superovulated tissue compared with unstimulated controls (Log 2 fold change: P Ͻ 0.05). Fig. 6 . A: comparison of differentially expressed genes in bovine endometrium on day 7 of pregnancy between superovulation and unstimulated controls (this study), elevated P4 concentrations within the physiological range and untreated controls (11) and superovulated vs. unstimulated endometrium recovered on day 13 (this study and Ref. 11). B: comparison of differentially expressed genes in the embryo (14) and the endometrium (this study) on day 7 following superovulation. Note that a significantly larger number of genes are altered in the endometrium and that the genes altered are predominantly unique to each tissue type.
sistent with the present data, in humans, comparison of endometrial biopsies from natural and stimulated cycles during the receptive phase (day 7) revealed the suppression of genes involved in cell cycle and cell division in stimulated cycles (22, 23) . We propose that in cattle, superovulation modulates the effect of P4 on endometrial cell proliferation; hence, in endometrium exposed to supraphysiological concentrations of P4, the expression of genes involved in cell cycle checkpoint control and p53 signaling are dysregulated compared with controls.
In addition to affecting endometrial cellular proliferation, there is clear evidence in cattle that an early postovulatory increase in P4 concentration, either via external manipulation or endogenously higher P4 concentrations results in a larger conceptus (6, 14, 38) , which produces more IFNT (30 -32) and increased pregnancy rates in both cattle and sheep (2, 33, 41) . Previous studies by our group have demonstrated that exogenous P4 supplementation enhances conceptus elongation on day 13 and 16 (6) associated with distinct alterations in the endometrial transcriptome which contribute to enhanced elongation (14) . Interestingly, such P4 supplementation altered the expression of the 124 genes on day 7 (14) but only 22 of these were altered in the model of superovulation (Fig. 6A) .
Despite there being little overlap between DEGs induced by superovulation and P4 supplementation on day 7, there was considerable overlap in the number of genes altered in superovulated endometria on day 7 and the number upregulated in unstimulated heifers on day 13, i.e., later luteal phase endometrium (Fig. 6A) . Moreover, the expression of these genes in superovulated endometria on day 7 displayed a similar fold change increase to later luteal phase endometria, indicating that the transcriptome of endometria from superovulated heifers on day 7 is more similar to endometria from single ovulating heifers on day 13 than single ovulating heifers on day 7. This notion that elevated P4 advances the temporal changes that normally occur in the uterus is consistent with our previous data (14) .
In humans, large numbers of DEGs are altered to establish uterine receptivity to implantation (36) , the modulation of which is significantly affected by controlled ovarian hyperstimulation (558 DEGs) procedures (26) . Moreover, the expression levels of a large proportion of genes that are temporally regulated during a normal cycle have an inverse expression pattern in endometria from stimulated women consistent with the findings of the present study. In addition, MET was recently reported by to be upregulated during the implantation window of natural cycles (25) but delayed in expression when hCG is given during a stimulation protocol using a GnRH agonist (4), as well as modulation of genes involved in cell cycle regulation (4, 22) . This supports the hypothesis that the process of superovulation/superstimulation affects the expression of genes in the endometrium in a similar manner, irrespective of species; however, at least in cattle, despite this asynchrony between the stage of embryo (blastocyst) and the endometrium (more similar to what is observed during the elongation process) normal embryo development occurs after transfer to an unstimulated recipient uterus.
A comparison of effect of superovulation on the transcriptome of the blastocyst (17) and the endometrium (this study) using the same data analysis criteria demonstrated that superovulation has distinct effects on the endometrium and on the embryo (Fig. 6B) . In addition to their being little overlap in the DEGs in both tissues, the manner in which these genes were altered was different. In the endometrium, approximately twothirds of genes affected by exposure to supraphysiological concentrations of P4 were upregulated and one-third were downregulated (64.5 and 35.5%, respectively); however, in the embryo 98.9% of DEGs in were upregulated in response to superovulation. P4 has been shown to affect the expression of genes in different cell types within the uterus in a variety of species (3) . The fact that the transcriptome of the embryo is distinct compared with other tissues with a large number of uniquely expressed transcripts (29) may explain, in part, why there is such a divergent effect of superovulation on the transcriptome of the embryo compared with the endometrium.
At first glance, the observations that superovulation induces dramatic changes in the endometrial (this study) and blastocyst (17) transcriptome compared with controls and that blastocysts Table 4 . Genes altered within 3 biological processes in both blastocyst (14) derived from such a treatment in cattle are apparently normal may seem incongruous. However, it is important to point out that in all of our previous studies examining the effects of elevated P4 on the endometrium (13) (14) (15) and the embryo (6, 7, 9) , elevated P4 did not affect the proportion of embryos forming blastocysts, either in vitro (9) or in vivo (6, 7) . In contrast, exposure to elevated P4 (or a uterus primed by elevated P4) in the posthatching phase results in advanced conceptus elongation. Thus, despite the changes induced in the transcriptome of the day 7 blastocyst due to superovulation (17) , transfer of such blastocysts to an unstimulated uterine environment, as is the norm in commercial bovine embryo transfer, apparently does not have any detrimental carryover effects of exposure to supraphysiological P4. In other words, it would appear that the changes induced by superovulation in the blastocyst reflect the plasticity of the embryo rather than having a functional consequence. That the same may not be true of the uterus, however, is supported by the fact that high-quality embryos transferred into women involved as embryo recipients in a surrogacy procedure have a higher likelihood of implanting than if they are transferred back into the stimulated donors (8, 40) .
Despite the evidence that P4 mediates its effects on the embryo during the process of elongation via indirect actions on the endometrium, worthy of consideration is the fact that up to the blastocyst stage of development in vivo, the embryo is exposed to an environment that is regulated by the prevailing P4 status of the animal. Supplementation of exogenous P4 modulates the composition of the oviduct and uterine lumen fluid to which the embryo is exposed (27) . In addition endoscopic transfer of zygotes into the oviduct of dairy cows (with lower circulating P4 concentrations) resulted in decreased blastocyst development compared with heifer controls (37) , indicating that up to the blastocyst stage of development the embryo is sensitive to the maternal P4 environment. Evidence in the literature also demonstrates that embryos grown in a modulated P4 environment in vivo (P4 supplementation or superovulation) have an altered transcriptome (7, 17, 34) . These alterations are relatively small (191 and 454 for high P4 and superovulated environments, respectively) and are likely more representative of the plasticity of the embryo.
In conclusion, during the process of superovulation in cattle both the endometrium and the embryo are exposed to superphysiological concentrations of P4. This induces significant changes in the transcriptome of both tissues; those induced in the endometrium are different to those that are altered in the embryo or indeed in models where P4 is manipulated within physiological ranges. Despite these alterations to both the embryo and the endometrium, no adverse effects on pregnancy rates are apparent following embryo recovery and transfer to unstimulated recipients. We propose that this is a result of P4 mediating its effects predominantly via the endometrium during the process of elongation, by which time the embryo has been transferred into the "normal" P4 environment of a synchronized unstimulated recipient.
